Q32 Bio (QTTB) Short-term Investments (2017 - 2025)

Q32 Bio's Short-term Investments history runs 9 years deep, the most recent figure standing at $19.9 million for Q3 2025.

• In Q3 2025, Short-term Investments changed N/A year-over-year to $19.9 million; the TTM figure through Sep 2025 stood at $19.9 million (changed N/A YoY), while the FY2022 annual figure was $141.0 million, up 196.98% from the prior year.
• Short-term Investments was $19.9 million for Q3 2025 at Q32 Bio, up from $10.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $157.9 million in Q3 2022 to a low of $8.0 million in Q1 2022.
• Historically, Short-term Investments has averaged $68.7 million across 5 years, with a median of $62.2 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Short-term Investments plunged 90.5% in 2022, then soared 1282.31% in 2023.
• A 5-year view of Short-term Investments shows it stood at $47.5 million in 2021, then jumped by 196.98% to $141.0 million in 2022, then slumped by 47.4% to $74.2 million in 2023, then slumped by 86.54% to $10.0 million in 2024, then jumped by 99.33% to $19.9 million in 2025.
• The last three Short-term Investments figures came in at $19.9 million (Q3 2025), $10.0 million (Q2 2024), and $19.8 million (Q1 2024), per Business Quant data.